Search Press releases Keywords From To 18 Oct 2018 UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis into Confirmatory Development Phase Read More 18 Oct 2018 The impact of fragility fractures due to osteoporosis is being ignored Read More 12 Oct 2018 Transparency notification BlackRock, Inc. Read More 5 Oct 2018 Transparency notifications BlackRock, Inc. Read More 2 Oct 2018 Transparency notifications BlackRock, Inc. Read More 24 Sep 2018 UCB Highlights Data to Be Presented At American Society for Bone and Mineral Research 2018 Annual Meeting Read More Pagination First page Previous page Previous … Page 65 Page 66 Page 67 Page 68 Current page 69 Page 70 Page 71 Page 72 Page 73 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
